Caitong International Asset Management’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
LCM
P
Caitong International Asset Management's CRDF Position: Q2 2026 in Review
Caitong International Asset Management reduced its Cardiff Oncology (CRDF) stake by 100% in Q2 2026, selling an estimated $35.4K and leaving 5 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #2704.
Caitong International Asset Management first reported a position in CRDF in Q4 2024 and has held it in 5 quarters since. The position peaked at $36.1K in Q1 2026. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.
- Caitong International Asset Management held 5 shares of Cardiff Oncology worth $6 as of Q2 2026.
- Caitong International Asset Management sold 22,290 Cardiff Oncology shares in Q2 2026, an estimated $35.4K.
- Cardiff Oncology made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2704 holding.
- Caitong International Asset Management first reported a position in Cardiff Oncology in Q4 2024 and has held it in 5 quarters since.
- Caitong International Asset Management's Cardiff Oncology position peaked at $36.1K in Q1 2026.
- 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.
Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.